dermatitis herpetiformis
MeSH: D003874ORPHA: 16561 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| dapsone | oral tablet 25mg, 50mg, 100mg; topical gel 5%, 7.5% | FDA Approved | 8 | 7d |
Clinical Presentation
Signs and symptoms associated with dermatitis herpetiformis, sourced from HPO and Orphanet clinical annotations.
PruritusUrticariaMicrocytic anemiaMalabsorptionRecurrent fracturesAutoimmunityAbnormal blistering of the skinErythemaGluten intoleranceMaculeSkin vesicleEczematoid dermatitisAnti-epidermal transglutaminase antibody positivityAnti-endomysial antibody positivityAnti-transglutaminase 6 antibodyAntigliadin antibody positivityAnti-reticulin antibody positivityAnti-type VII collagen antibodyDelayed eruption of teethAbnormality of the thyroid glandEdemaBone painDental enamel pitsLichenificationAbnormality of the nervous systemErosion of oral mucosa
Classification & Codes
MeSH Code
D003874Orphanet Code
ORPHA:1656dermatitis herpetiformis
| MeSH | D003874 |
| Orphanet | ORPHA:1656 |
| Treatments | 1 drug(s) |
| Symptoms on record | 26 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO